Unlock instant, AI-driven research and patent intelligence for your innovation.

Polysaccharide sulfate dispersible tablet

A technology of sodium alginate diester and dispersible tablets, which is applied in the field of dispersible tablets and can solve the problems of low bioavailability and slow onset of action

Active Publication Date: 2014-04-16
CP PHARMA QINGDAO CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] In order to solve the shortcomings of the existing sodium alginate diester preparations, such as slow onset of action and low bioavailability, the present invention has invented a sodium alginate diester inclusion compound dispersible tablet

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polysaccharide sulfate dispersible tablet
  • Polysaccharide sulfate dispersible tablet
  • Polysaccharide sulfate dispersible tablet

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Sodium alginate diester inclusion compound: sodium alginate diester: hydroxypropyl β-cyclodextrin is 6.3:3.7

[0022] The prescription for dispersible tablets is (by weight):

[0023]

[0024]

[0025] Preparation:

[0026] 1. Prepare sodium alginate diester inclusion compound according to the following method:

[0027] (1) In water or aqueous ethanol medium, react sodium alginate diester with hydroxypropyl β-cyclodextrin in a certain proportion, filter the resulting solution through a microporous membrane until it is clear, and separate the package from the mixture. compounds; or

[0028] (2) In solid form, react sodium alginate diester with hydroxypropyl β-cyclodextrin; or

[0029] (3) Sodium alginate diester reacts with hydroxypropyl β-cyclodextrin for high-energy grinding.

[0030] 2. Mix the prescription amount of low-substituted hydroxypropyl cellulose, sorbitol, sodium cyclamate and alginate diester sodium inclusion compound according to the equal addit...

Embodiment 2

[0032] Sodium alginate diester inclusion compound: sodium alginate diester: hydroxypropyl β-cyclodextrin is 6.3:3.7

[0033] The prescription for dispersible tablets is (by weight):

[0034]

[0035] The preparation method is the same as above

Embodiment 3

[0037] Sodium alginate diester inclusion compound: sodium alginate diester: hydroxypropyl β-cyclodextrin is 6.3:3.7

[0038] The prescription for dispersible tablets is (by weight):

[0039]

[0040] The preparation method is the same as above

[0041] Control group 1

[0042] The prescription for dispersible tablets is (by weight):

[0043]

[0044] The preparation method is the same as above

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The application relates to a vitamin C clathrate compound dispersible tablet. Firstly, vitamin C is prepared into clathrate compound, and is then prepared into the dispersible tablet.

Description

technical field [0001] The present application relates to a dispersible tablet, specifically, a dispersible tablet of sodium alginate diester inclusion compound. Background technique [0002] Propyleneglycolalginatesodiumsulfate (PSS) is China's first marine sugar drug developed by Ocean University of my country. Prevention and treatment. PSS has been used clinically for more than 20 years, mainly for ischemic cerebrovascular diseases such as cerebral thrombosis, cerebral embolism, transient ischemic attack and cardiovascular diseases such as hypertension, hyperlipoproteinemia, coronary heart disease, Prevention and treatment of diseases such as angina pectoris. The total effective rate of PSS in the treatment of cardiovascular and cerebrovascular diseases is 80%~95%. With the clinical use and research, it has also been found that PSS has good curative effect on other diseases, such as cancer, diabetes, chronic kidney disease. glomerulonephritis, hepatitis, [0003] Psori...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/20A61K31/737A61K47/40A61P9/10A61P9/12A61P7/02A61P3/10A61P35/00A61P13/12A61P1/16A61P17/06A61P3/06
Inventor 王明刚任莉陈阳生
Owner CP PHARMA QINGDAO CO LTD